Park S - Search Results

1

Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients.

Kim I, Koh Y, Yoon SS, Park S, Kim BK, Kim DY, Lee JH, Lee KH, Cheong JW, Lee HK, Kim SH, Kim H, Joo YD, Lee SM, Won JH, Park SK, Hong DS, Kim SH, Sohn SK, Kim CS, Park E, Kim MK, Park MR, Lee JH, Min YH; Korean Society of Hematology AML/MDS working party. Kim I, et al. Among authors: park e, park s, park sk, park mr. Am J Hematol. 2013 Jan;88(1):10-5. doi: 10.1002/ajh.23337. Epub 2012 Oct 17. Am J Hematol. 2013. PMID: 23077109 Free article. Clinical Trial.

2

Successful eradication of relapsed primary effusion lymphoma with high-dose chemotherapy and autologous stem cell transplantation in a patient seronegative for human immunodeficiency virus.

Won JH, Han SH, Bae SB, Kim CK, Lee NS, Lee KT, Park SK, Hong DS, Lee DW, Park HS. Won JH, et al. Int J Hematol. 2006 May;83(4):328-30. doi: 10.1532/IJH97.A30510. Int J Hematol. 2006. PMID: 16757433

3

Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience.

Yoo SH, Koh Y, Kim DY, Lee JH, Lee JH, Lee KH, Yoon SS, Park S, Park SK, Hong DS, Yi HG, Kim CS, Jang JE, Cheong JW, Moon J, Min YH, Sohn SK, Kim I; Korean Society of Blood and Marrow Transplantation. Yoo SH, et al. Among authors: park s, park sk. Ann Hematol. 2017 Apr;96(4):605-615. doi: 10.1007/s00277-017-2919-8. Epub 2017 Jan 16. Ann Hematol. 2017. PMID: 28091736

4

Combination of gemcitabine and cisplatin as first-line therapy in advanced non-small-cell lung cancer.

Lee NS, Byun JH, Bae SB, Kim CK, Lee KT, Park SK, Won JH, Hong DS, Park HS. Lee NS, et al. Cancer Res Treat. 2004 Jun;36(3):173-7. doi: 10.4143/crt.2004.36.3.173. Epub 2004 Jun 30. Cancer Res Treat. 2004. PMID: 20396540 Free PMC article.

5

Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis.

Shin DY, Kim SJ, Yoon DH, Park Y, Kong JH, Kim JA, Kim BS, Kim HJ, Won JH, Park SK, Kim WS. Shin DY, et al. Cancer Chemother Pharmacol. 2016 Apr;77(4):865-73. doi: 10.1007/s00280-016-3005-y. Epub 2016 Mar 16. Cancer Chemother Pharmacol. 2016. PMID: 26984211 Clinical Trial.

6

A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome.

Jeong SH, Kim YJ, Lee JH, Kim YK, Kim SJ, Park SK, Do YR, Kim I, Mun YC, Kim HG, Lee WS, Yi HG, Joo YD, Choi CW, Kim SR, Na SM, Jang JH. Jeong SH, et al. Oncotarget. 2015 Dec 29;6(42):44985-94. doi: 10.18632/oncotarget.6242. Oncotarget. 2015. PMID: 26517692 Free PMC article.

7

Phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with recurrent or metastatic gastric cancer.

Kim KH, Jeung KJ, Kim HJ, Bae SB, Kim CK, Lee NS, Lee KT, Park SK, Won JH, Hong DS, Park HS. Kim KH, et al. Cancer Res Treat. 2007 Jun;39(2):49-53. doi: 10.4143/crt.2007.39.2.49. Epub 2007 Jun 30. Cancer Res Treat. 2007. PMID: 19746213 Free PMC article.

8

A phase II study of irinotecan, 5-fluorouracil and leucovorin for treatment in patients with previously untreated advanced colorectal cancer.

Bae SB, Lee NS, Kim HJ, Kim KH, Kim HJ, Kim CK, Lee KT, Park SK, Won JH, Hong DS, Park HS. Bae SB, et al. Cancer Res Treat. 2006 Apr;38(2):72-7. doi: 10.4143/crt.2006.38.2.72. Epub 2006 Apr 30. Cancer Res Treat. 2006. PMID: 19771263 Free PMC article.

9

A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer.

Kim HJ, Lee NS, Lee SC, Bae SB, Kim CK, Cheon YG, Kim YS, Moon JH, Cho YD, Park SH, Lee KT, Park SK, Won JH, Park HS, Hong DS. Kim HJ, et al. Cancer Chemother Pharmacol. 2009 Jul;64(2):371-7. doi: 10.1007/s00280-008-0883-7. Epub 2009 Jan 14. Cancer Chemother Pharmacol. 2009. PMID: 19142638 Clinical Trial.

10

R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma.

Lee HG, Choi Y, Kim SY, Kim I, Kim YK, Kim YS, Lee HS, Kim SJ, Kim JA, Park BB, Park J, Shim H, Eom HS, Lee J, Park SK, Cheong JW, Park KW. Lee HG, et al. Blood Res. 2014 Jun;49(2):107-14. doi: 10.5045/br.2014.49.2.107. Epub 2014 Jun 25. Blood Res. 2014. PMID: 25025012 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66,028 results

Search Page

Filters